Langerhans Cell Histiocytosis (LCH) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis
Condition: Pulmonary Langerhans Cell Histiocytosis Intervention: Sponsors: University of Cincinnati; Rare Diseases Clinical Research Network; National Heart, Lung, and Blood Institute (NHLBI) Recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2017 Category: Research Source Type: clinical trials